Edward O'Neill (@NuclearMedEd) header
Edward O'Neill (@NuclearMedEd) profile picture

PCUK Career Acceleration Fellow @UniofOxford šŸ‡¬šŸ‡§ working to improve radionuclide treatment of prostate cancer with novel drug combinationsšŸ’Š+ā˜¢ļø.

Oxford
Joined April 2020
Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)Photo by Edward O'Neill (@NuclearMedEd)
Edward O'Neill retweeted
Postdoc/RA jobs in new #radiobiology group @unioxford •Funder @PCF_Science •Co-supervision @ProfClaireEd •Collab with @OxPCaBiol Project: Identify metabolic signatures in #prostatecancer 🦓 mets w/ PET imaging for tailored šŸ’Š + ā˜¢ļøcombos t.ly/3iIrL Cl 17 Jan
1
14
1
17
4,111
UK contingent at #PCFRetreat23 Fantastic science, and so great to catch up with friends and colleagues after 4y! Thanks @PCF_Science
1
3
38
2,117
We are thrilled to announced that Dr Edward O'Neill will join our department after securing a prestigious Prostate Cancer UK Career Acceleration Fellowship. Congrats and welcome to NDS, @NuclearMedEd! šŸŽ‰ āž”ļø nds.ox.ac.uk/news/edward-one… @ProstateUKProfs @ProstateUKPress @ProstateUK
3
3
18
3,687
NEW: Oxford's #cancer research has received Ā£11 million investment from @CRUKresearch! The funding for @OxfordCancer and @OUH_Research will be invested in: • Early detection • Novel therapeutics & diagnostics • Developments in immuno-oncology • Cancer big data Read moreā¬‡ļø

1
22
5
80
Edward O'Neill retweeted
Animation showing the pharmacokinetics of a Lu-PSMA radionuclide therapy for treatment of metastatic prostate cancer. Mapping the rate of uptake and clearance is necessary to estimate the effect in each cycle of treatment which in turn allows more personalised prescription.
2
39
2
90
Edward O'Neill retweeted
Results released by @ASCO & @Novartis on the Phase 3 VISION trial testing the addition of 177Lu-PSMA-617 to standard of care in mCRPC. Significant improvements in median rPFS (8.7 vs 3.4 months) & median Overall Survival (15.3 vs 11.3 months). #ASCO21 asco.org/about-asco/press-ce…
2
28
5
74
NEW: Oxford researchers find malaria vaccine is highly effective: • Vaccine efficacy of 77% in African children • Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated More info ā¬‡ļø https://nitter.cf/t.co/vOvEuICo2Q

135
3,509
1,471
11,593
Edward O'Neill retweeted
Super exciting new study showing SARS-CoV-2 recruits a haem metabolite to evade antibodies to the N-terminal domain of Spike – all started from a curious observation: colour change in purified protein... medrxiv.org/content/10.1101/…
7
49
16
193
The ChAdOx1 nCoV-19 vaccine against SARS-CoV-2, which is currently undergoing human clinical trials in the UK, elicits an immune response and reduces the viral load in macaques exposed to SARS-CoV-2, according to a Nature paper. go.nature.com/310Dwoa
16
152
20
363
Oxford’s Covid-19 vaccine produces a good immune response, reveals new study. Teams at @VaccineTrials and @OxfordVacGroup have found there were no safety concerns, and the vaccine stimulated strong immune responses: https://nitter.cf/t.co/krqRzXMh7B
1,448
22,757
4,688
50,930
Our latest "Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following alpha- and beta-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Got the cover too! thno.org/v10p5802.htm #Theranostics
5
2
56
Thank you to everyone who supported ā€œ150 years of Nature,ā€ which won two @TheWebbyAwards! Watch the video below.
4
57
25
217
Edward O'Neill retweeted
A new study published in The Journal of Nuclear Medicine has demonstrated that molecular imaging can identify early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients. #NeuroendocrineCancer #MedicalResearch #NuclearMedicine #JNM ow.ly/aUq050zFJf0
1
14
1
19
Edward O'Neill retweeted
Promising new preprint from UK+US researchers showing that a single injection of the Oxford adenovirus that encodes the #COVID19 #SARSCoV2 spike protein (ChAdOx1) serves as an effective vaccine in monkeys, blocking pneumonia & greatly lowering viral load.šŸ‘biorxiv.org/content/10.1101/…
29
403
65
1,061
Edward O'Neill retweeted
ANNOUNCEMENT: Today SNMMI President Vasken Dilsizian, MD, unveiled the re-imagined SNMMI 2020 Annual Meeting—Virtual Edition! This virtual experience, on July 11-14, will be FREE to SNMMI members, discounted for nonmembers. ow.ly/PwT030qC5h3 #SNMMI20 #NuclearMedicine
2
30
4
42